We're only selling about $1.5M in revs with mfg capacity for $20M - how much can you forward value the opportunity in a stock price today? I agree it is undervalued at $0.15/share, but the company has a lot lot to prove to warrant something much above a $1. They have not sold or made GenPrecis at any volume and that is still likely two quarters away with the idea that revenue will start to grow in 2018.

Throw in all of the other issues around OTC status, where the J&J case is going and there are far more unknowns than knowns, so the share price is where it is.

I'm not negative on the company and like their future prospects, but there are certain realities in play. In most cases, we are very far removed from much of the detail as to what is really going on, so patience and some positive thought is in order for the next few weeks. Speculation and pondering is great if it helps you justify your position, but of little value until something actually happens or is reported.